On June 2, 2018, National Cancer Institute (NCI) Director Norman E. Sharpless, M.D. presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois regarding the power and promise of cancer research. He discussed his four key focus areas which are Basic Science, Workforce, Big Data and Clinical Trials. #ASCO18 https://www.cancer.gov/about-nci/leadership/director/presentations/sharpless-asco-2018
Learn more at www.AACR.org/Targets17
Tuesday, April 17, 2018 10:30 a.m.–12:30 p.m. Novel Immuno-oncology Strategies
Hear from medical experts from the NCI and Cleveland Clinic as they discuss why MBC has no cure to date. http://ume3.org
The secret is out…please welcome the National Credentialing Institute to the association profession. Check out our press conference hosted by Association Chat Live from ASAE18. NCI is developing a series of Micro-burst learning webinars, in addition to Micro-credentials for those professionals in association, chamber and non-profit management. The first modules released will be Diversity & Inclusion Micro-credential Take your career to the next level with NCI!
2018 Demystifying Medicine: The New Frontier: Immunotherapy of cancer Air date: Tuesday, February 6, 2018, 4:00:00 PM Category: Demystifying Medicine Runtime: 01:46:18 Description: The Demystifying Medicine Lecture Series is designed to help bridge the gap between advances in biology and their applications to major human diseases. The lectures include presentations of patients, pathology, diagnosis, and therapy in the context of major diseases and current research. All clinicians, trainees including fellows, medical students, Ph.D. students, and other healthcare and research professionals are welcome to attend. For more information go to https://demystifyingmedicine.od.nih.gov Author: James Gulley, MD, PhD, NCI, NIH and James Hodges, PhD, MBA, NCI, NIH Permanent link: https://videocast.nih.gov/launch.asp?23701
The National Cancer Institute’s Small Business Innovation Research (SBIR) Development Center provides special funding opportunities for small businesses through the Small Business Innovation Research/Small Business Technology Transfer program, one of the nation’s largest sources of financing for technology innovation. On June 14 at 1pm ET, join Michael Weingarten, Director of the NCI SBIR Development Center, and previous SBIR awardees Aruna Gambhir, CEO of CellSight Technologies and Guy Diperro, Founder of Chrono Therapeutics, as they discuss funding opportunities and entrepreneurial support provided by the NCI SBIR Development Center. http://www.cancer.gov/research